サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1361747

創傷治療用生物製剤の世界市場レポート

Global Wound Care Biologics Market Report
出版日: | 発行: Value Market Research | ページ情報: 英文 182 Pages | 納期: 即日から翌営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.14円
創傷治療用生物製剤の世界市場レポート
出版日: 2023年10月01日
発行: Value Market Research
ページ情報: 英文 182 Pages
納期: 即日から翌営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

創傷治療用生物製剤市場の世界需要は、2023年～2030年の調査期間中にCAGR6.4%で成長し、2022年の263万米ドルから2030年までに406万米ドル近くの市場規模に達すると予測されます。

創傷治療用生物製剤は、治癒しない下肢の創傷を治療するために使用される生物工学製品です。創傷治療のあらゆる段階が創傷生物学的製剤の対象となります。これには創傷のタイプの決定、創傷治癒に影響する要素の特定、適切な創傷管理療法の適用などが含まれます。創傷生物学は創傷治療の各ステップをカバーします。これには創傷のタイプを特定し、創傷治癒に影響する要素を特定し、適切な創傷管理療法を実施することが含まれます。創傷が評価され、すべての要件が検討されると、治療施設は最善の治療法を決定することができます。

市場力学：

熱傷の有病率は上昇傾向にあり、交通事故とそれによる外傷が増加しています。こうした動向が市場拡大の原動力となっています。しかし、この市場拡大の主な障壁は、生物学的創傷治療薬の高価格と代用皮膚失敗の危険性です。とはいえ、糖尿病性潰瘍の早期治療によって感染症、入院、切断などの重篤な合併症を予防できるため、創傷治療用生物製剤の需要は飛躍的に高まると予想されます。さらに、市販されている代用皮膚は、創傷治癒における有効性が臨床的・科学的に証明されており、市場をさらに前進させています。

この調査レポートは、ポーターのファイブフォースモデル、市場魅力度分析、バリューチェーン分析を網羅しています。これらのツールは、業界の構造を明確に把握し、世界レベルでの競合の魅力を評価するのに役立ちます。さらに、これらのツールは創傷治療用生物製剤の世界市場における各セグメントを包括的に評価することもできます。創傷治療用生物製剤産業の成長と動向は、この調査に全体的なアプローチを提供します。

地域分析：

本セクションでは、北米、欧州、アジア太平洋、ラテンアメリカ、中東・アフリカにおける創傷治療用生物製剤市場の現在と将来の需要を強調する地域展望をカバーします。さらに、本レポートでは、すべての主要地域における個々のアプリケーションセグメントの需要、推定・予測に焦点を当てています。

ご要望がございましたら、弊社までご連絡ください。当社の調査チームは、お客様のニーズに応じてカスタマイズしたレポートを提供することができます。

目次

第1章 序文

第2章 エグゼクティブサマリー

  • 市場のハイライト
  • 世界市場スナップショット

第3章 創傷治療用生物製剤：産業分析

  • イントロダクション：市場力学
  • 市場促進要因
  • 市場抑制要因
  • 市場機会
  • 業界動向
  • ポーターのファイブフォース分析
  • 市場魅力度分析

第4章 バリューチェーン分析

  • バリューチェーン分析
  • 原材料分析
    • 原材料リスト
    • 原材料メーカーリスト
    • 主要原材料の価格動向
  • 潜在的バイヤーのリスト
  • マーケティングチャネル
    • ダイレクトマーケティング
    • インダイレクトマーケティング
    • マーケティングチャネル発展動向

第5章 COVID-19発生の影響分析

第6章 創傷治療用生物製剤の世界市場分析：製品別

  • 製品別概要
  • 実績データと予測データ
  • 製品別分析
  • 生物学的皮膚代替物（ヒトドナー組織由来製品、アセラー動物由来製品、生合成製品）
  • 外用剤
  • その他

第7章 創傷治療用生物製剤の世界市場分析：創傷タイプ別

  • 創傷タイプ別概要
  • 実績データと予測データ
  • 創傷タイプ別分析
  • 潰瘍（糖尿病性足潰瘍、静脈性潰瘍、褥瘡、その他の潰瘍）
  • 外科的および外傷性創傷
  • 熱傷
  • その他の創傷ケア

第8章 創傷治療用生物製剤の世界市場売上分析：エンドユーザー別

  • エンドユーザー別概要
  • 実績データと予測データ
  • エンドユーザー別分析
  • 病院
  • 外来手術センター
  • 火傷治療センター、創傷クリニック、在宅環境

第9章 創傷治療用生物製剤の世界市場売上分析：地域別

  • 地域別展望
  • イントロダクション
  • 北米の売上分析
    • 概要、実績と予測
    • 北米：セグメント別
    • 北米：国別
    • 米国
    • カナダ
    • メキシコ
  • 欧州の売上分析
    • 概要、実績と予測
    • 欧州：セグメント別
    • 欧州：国別
    • 英国
    • フランス
    • ドイツ
    • イタリア
    • ロシア
    • その他欧州
  • アジア太平洋地域の売上分析
    • 概要、実績と予測
    • アジア太平洋地域：セグメント別
    • アジア太平洋地域：国別
    • 中国
    • インド
    • 日本
    • 韓国
    • オーストラリア
    • その他アジア太平洋地域
  • ラテンアメリカの売上分析
    • 概要、実績と予測
    • ラテンアメリカ：セグメント別
    • ラテンアメリカ：国別
    • ブラジル
    • アルゼンチン
    • ペルー
    • チリ
    • その他ラテンアメリカ
  • 中東・アフリカの売上分析
    • 概要、実績と予測
    • 中東・アフリカ：セグメント別
    • 中東・アフリカ：国別
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • 南アフリカ
    • その他中東・アフリカ

第10章 創傷治療用生物製剤企業の競合情勢

  • 創傷治療用生物製剤市場の競合
  • 提携/協力/合意
  • 合併・買収
  • 新製品の上市
  • その他の開発

第11章 企業プロファイル

  • 上位10社のシェア分析
  • 市場集中度
  • Smith & Nephew plc（UK）
  • Organogenesis Inc.（US）
  • MIMEDX（US）
  • Integra LifeSciences（US）
  • Stryker Corporation（US）
図表

LIST OF TABLES

  • Market Snapshot
  • Drivers : Impact Analysis
  • Restraints : Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • List of Potential Buyers
  • Analysis by Product (USD MN)
  • Biological Skin Substitutes (Human Donor Tissue-derived Products, Acellular Animal-derived Products, Biosynthetic Products) Market Sales by Geography (USD MN)
  • Topical Agents Market Sales by Geography (USD MN)
  • Others Market Sales by Geography (USD MN)
  • Analysis Market by Wound Type (USD MN)
  • Ulcers(Diabetic Foot Ulcers, Venous Ulcers, Pressure Ulcers, Other Ulcers) Market Sales by Geography (USD MN)
  • Surgical & Traumatic Wounds Market Sales by Geography (USD MN)
  • Burns Market Sales by Geography (USD MN)
  • Others Wound Type Market Sales by Geography (USD MN)
  • Analysis by End User (USD MN)
  • Hospitals Market Sales by Geography (USD MN)
  • Ambulatory Surgery Centers Market Sales by Geography (USD MN)
  • Burn Care Centers & Wound Clinics and Home Settings Market Sales by Geography (USD MN)
  • Global Wound Care Biologics Market Sales by Geography (USD MN)
  • North America Market Analysis (USD MN)
  • United State Market Analysis (USD MN)
  • Canada Market Analysis (USD MN)
  • Mexico Market Analysis (USD MN)
  • Europe Market Analysis (USD MN)
  • Europe Market Estimate by Country (USD MN)
  • United Kingdom Market Analysis (USD MN)
  • France Market Analysis (USD MN)
  • Germany Market Analysis (USD MN)
  • Italy Market Analysis (USD MN)
  • Russia Market Analysis (USD MN)
  • Spain Market Analysis (USD MN)
  • Rest of Europe Market Analysis (USD MN)
  • Asia Pacific Market Analysis (USD MN)
  • China Market Analysis (USD MN)
  • Japan Market Analysis (USD MN)
  • India Market Analysis (USD MN)
  • South Korea Market Analysis (USD MN)
  • Australia Market Analysis (USD MN)
  • Rest of Asia Pacific Market Analysis (USD MN)
  • Latin America Market Analysis (USD MN)
  • Brazil Market Analysis (USD MN)
  • Argentina Market Analysis (USD MN)
  • Peru Market Analysis (USD MN)
  • Chile Market Analysis (USD MN)
  • Rest of Latin America Market Analysis (USD MN)
  • Middle East & Africa Market Analysis (USD MN)
  • Saudi Arabia Market Analysis (USD MN)
  • UAE Market Analysis (USD MN)
  • Israel Market Analysis (USD MN)
  • South Africa Market Analysis (USD MN)
  • Rest of Middle East and Africa Market Analysis (USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisition

LIST OF FIGURES

  • Research Scope of Wound Care Biologics Report
  • Market Research Process
  • Market Research Methodology
  • Global Wound Care Biologics Market Size, by Region (USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis by Product
  • Market Attractiveness Analysis by Wound Type
  • Market Attractiveness Analysis by End User
  • Market Attractiveness Analysis by Region
  • Value Chain Analysis
  • Global Market Analysis by Product (USD MN)
  • Biological Skin Substitutes (Human Donor Tissue-derived Products, Acellular Animal-derived Products, Biosynthetic Products) Market Sales by Geography (USD MN)
  • Topical Agents Market Sales by Geography (USD MN)
  • Others Market Sales by Geography (USD MN)
  • Global Market Analysis by Wound Type (USD MN)
  • Ulcers(Diabetic Foot Ulcers, Venous Ulcers, Pressure Ulcers, Other Ulcers) Market Sales by Geography (USD MN)
  • Surgical & Traumatic Wounds Market Sales by Geography (USD MN)
  • Burns Market Sales by Geography (USD MN)
  • Others Wound Type Market Sales by Geography (USD MN)
  • Global Market Analysis by End User (USD MN)
  • Hospitals Market Sales by Geography (USD MN)
  • Ambulatory Surgery Centers Market Sales by Geography (USD MN)
  • Burn Care Centers & Wound Clinics and Home Settings Market Sales by Geography (USD MN)
  • Global Market by Revenue
  • North America Market by Revenue
  • Europe Market by Revenue
  • Asia Pacific Market by Revenue
  • Latin America Market by Revenue
  • Middle East & Africa Market by Revenue
  • Recent Development in Industry
  • Top Company Share Analysis

Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.

目次
Product Code: VMR11218730

The global demand for Wound Care Biologics Market is presumed to reach the market size of nearly USD 4.06 MN by 2030 from USD 2.63 MN in 2022 with a CAGR of 6.4% under the study period 2023 - 2030.

Wound care biologics are bioengineered products used to treat non-healing lower extremity wounds. Every stage of wound management is covered under wound biologics. This includes determining the wound type, specifying elements that affect wound healing, and applying the appropriate wound management therapy. Wound biologics cover each step of wound care. This entails identifying the type of wound, pinpointing factors that influence wound healing, and implementing the appropriate wound management therapy. Once the wound has been evaluated, and all requirements have been examined, the treatment facility can decide on the best treatment options.

MARKET DYNAMICS:

The prevalence of burn injuries is rising, and there are more car accidents and the traumatic injuries they cause. These trends are driving the market expansion. The main barriers to the expansion of this market, however, are the high price of biologic wound care treatments and the danger of skin substitute failure. Nonetheless, as early treatment of diabetic ulcers can prevent serious complications like infection, hospitalisation, and amputation, demand for wound care biologic products is anticipated to rise dramatically. Furthermore, the commercially available skin substitutes offer clinical and scientific proof of efficacy in wound healing, further propelling the market forward.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of wound care biologics. The growth and trends of wound care biologics industry provide a holistic approach to this study.

MARKET SEGMENTATION:

This section of the wound care biologics market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Product

  • Biological Skin Substitutes (Human Donor Tissue-Derived Products, Acellular Animal-Derived Products, Biosynthetic Products)
  • Topical Agents
  • Others

By Wound Type

  • Ulcers(Diabetic Foot Ulcers, Venous Ulcers, Pressure Ulcers, Other Ulcers)
  • Surgical & Traumatic Wounds
  • Burns
  • Others Wound Type

By End User

  • Hospitals
  • Ambulatory Surgery Centers
  • Burn Care Centers & Wound Clinics and Home Settings

REGIONAL ANALYSIS:

This section covers the regional outlook, which accentuates current and future demand for the Wound Care Biologics market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the wound care biologics market include Smith & Nephew plc (UK), Organogenesis Inc. (US), MIMEDX (US), Integra LifeSciences (US), and Stryker Corporation (US). This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1 . PREFACE

  • 1.1. Report Description
    • 1.1.1. Objective
    • 1.1.2. Target Audience
    • 1.1.3. Unique Selling Proposition (USP) & offerings
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1. Market Research Process
    • 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

  • 2.1. Highlights of Market
  • 2.2. Global Market Snapshot

3 . WOUND CARE BIOLOGICS - INDUSTRY ANALYSIS

  • 3.1. Introduction - Market Dynamics
  • 3.2. Market Drivers
  • 3.3. Market Restraints
  • 3.4. Opportunities
  • 3.5. Industry Trends
  • 3.6. Porter's Five Force Analysis
  • 3.7. Market Attractiveness Analysis
    • 3.7.1 Market Attractiveness Analysis By Product
    • 3.7.2 Market Attractiveness Analysis By Wound Type
    • 3.7.3 Market Attractiveness Analysis By End User
    • 3.7.4 Market Attractiveness Analysis By Region

4 . VALUE CHAIN ANALYSIS

  • 4.1. Value Chain Analysis
  • 4.2. Raw Material Analysis
    • 4.2.1. List of Raw Materials
    • 4.2.2. Raw Material Manufactures List
    • 4.2.3. Price Trend of Key Raw Materials
  • 4.3. List of Potential Buyers
  • 4.4. Marketing Channel
    • 4.4.1. Direct Marketing
    • 4.4.2. Indirect Marketing
    • 4.4.3. Marketing Channel Development Trend

5 . IMPACT ANALYSIS OF COVID-19 OUTBREAK

6 . GLOBAL WOUND CARE BIOLOGICS MARKET ANALYSIS BY PRODUCT

  • 6.1 Overview by Product
  • 6.2 Historical and Forecast Data
  • 6.3 Analysis by Product
  • 6.4 Biological Skin Substitutes (Human Donor Tissue-derived Products, Acellular Animal-derived Products, Biosynthetic Products) Historic and Forecast Sales by Regions
  • 6.5 Topical Agents Historic and Forecast Sales by Regions
  • 6.6 Others Historic and Forecast Sales by Regions

7 . GLOBAL WOUND CARE BIOLOGICS MARKET ANALYSIS BY WOUND TYPE

  • 7.1 Overview by Wound Type
  • 7.2 Historical and Forecast Data
  • 7.3 Analysis by Wound Type
  • 7.4 Ulcers(Diabetic Foot Ulcers, Venous Ulcers, Pressure Ulcers, Other Ulcers) Historic and Forecast Sales by Regions
  • 7.5 Surgical & Traumatic Wounds Historic and Forecast Sales by Regions
  • 7.6 Burns Historic and Forecast Sales by Regions
  • 7.7 Other Wound Care Historic and Forecast Sales by Regions

8 . GLOBAL WOUND CARE BIOLOGICS MARKET SALES ANALYSIS BY END USER

  • 8.1 Overview by End User
  • 8.2 Historical and Forecast Data
  • 8.3 Analysis by End User
  • 8.4 Hospitals Historic and Forecast Sales by Regions
  • 8.5 Ambulatory Surgery Centers Historic and Forecast Sales by Regions
  • 8.6 Burn Care Centers & Wound Clinics and Home Settings Historic and Forecast Sales by Regions

9 . GLOBAL WOUND CARE BIOLOGICS MARKET SALES ANALYSIS BY GEOGRAPHY

  • 9.1. Regional Outlook Sales Analysis
  • 9.2. Introduction Sales Analysis
  • 9.3. North America Sales Analysis
    • 9.3.1. Overview, Historic and Forecast Sales Analysis
    • 9.3.2. North America By Segment Sales Analysis
    • 9.3.3. North America By Country Sales Analysis
    • 9.3.4. United State Sales Analysis
    • 9.3.5. Canada Sales Analysis
    • 9.3.6. Mexico Sales Analysis
  • 9.4. Europe Sales Analysis
    • 9.4.1. Overview, Historic and Forecast Sales Analysis
    • 9.4.2. Europe by Segment Sales Analysis
    • 9.4.3. Europe by Country Sales Analysis
    • 9.4.4. United Kingdom Sales Analysis
    • 9.4.5. France Sales Analysis
    • 9.4.6. Germany Sales Analysis
    • 9.4.7. Italy Sales Analysis
    • 9.4.8. Russia Sales Analysis
    • 9.4.9. Rest Of Europe Sales Analysis
  • 9.5. Asia Pacific Sales Analysis
    • 9.5.1. Overview, Historic and Forecast Sales Analysis
    • 9.5.2. Asia Pacific by Segment Sales Analysis
    • 9.5.3. Asia Pacific by Country Sales Analysis
    • 9.5.4. China Sales Analysis
    • 9.5.5. India Sales Analysis
    • 9.5.6. Japan Sales Analysis
    • 9.5.7. South Korea Sales Analysis
    • 9.5.8. Australia Sales Analysis
    • 9.5.9. Rest Of Asia Pacific Sales Analysis
  • 9.6. Latin America Sales Analysis
    • 9.6.1. Overview, Historic and Forecast Sales Analysis
    • 9.6.2. Latin America by Segment Sales Analysis
    • 9.6.3. Latin America by Country Sales Analysis
    • 9.6.4. Brazil Sales Analysis
    • 9.6.5. Argentina Sales Analysis
    • 9.6.6. Peru Sales Analysis
    • 9.6.7. Chile Sales Analysis
    • 9.6.8. Rest of Latin America Sales Analysis
  • 9.7. Middle East & Africa Sales Analysis
    • 9.7.1. Overview, Historic and Forecast Sales Analysis
    • 9.7.2. Middle East & Africa by Segment Sales Analysis
    • 9.7.3. Middle East & Africa by Country Sales Analysis
    • 9.7.4. Saudi Arabia Sales Analysis
    • 9.7.5. UAE Sales Analysis
    • 9.7.6. Israel Sales Analysis
    • 9.7.7. South Africa Sales Analysis
    • 9.7.8. Rest Of Middle East And Africa Sales Analysis

10 . COMPETITIVE LANDSCAPE OF THE WOUND CARE BIOLOGICS COMPANIES

  • 10.1. Wound Care Biologics Market Competition
  • 10.2. Partnership/Collaboration/Agreement
  • 10.3. Merger And Acquisitions
  • 10.4. New Product Launch
  • 10.5. Other Developments

11 . COMPANY PROFILES OF WOUND CARE BIOLOGICS INDUSTRY

  • 11.1. Top 10 Company Share Analysis
  • 11.2. Market Concentration Rate
  • 11.3. Smith & Nephew plc (UK)
    • 11.3.1. Company Overview
    • 11.3.2. Company Revenue
    • 11.3.3. Products
    • 11.3.4. Recent Developments
  • 11.4. Organogenesis Inc. (US)
    • 11.4.1. Company Overview
    • 11.4.2. Company Revenue
    • 11.4.3. Products
    • 11.4.4. Recent Developments
  • 11.5. MIMEDX (US)
    • 11.5.1. Company Overview
    • 11.5.2. Company Revenue
    • 11.5.3. Products
    • 11.5.4. Recent Developments
  • 11.6. Integra LifeSciences (US)
    • 11.6.1. Company Overview
    • 11.6.2. Company Revenue
    • 11.6.3. Products
    • 11.6.4. Recent Developments
  • 11.7. Stryker Corporation (US)
    • 11.7.1. Company Overview
    • 11.7.2. Company Revenue
    • 11.7.3. Products
    • 11.7.4. Recent Developments

Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies